XVIVO — Xvivo Perfusion AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual balance sheet for Xvivo Perfusion AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	399	246	546	415	292
Net Total Accounts Receivable
Net Total Receivables	63.9	104	139	141	148
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	548	468	826	813	688
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26.3	47.6	97.6	149	214
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,543	1,733	2,181	2,403	2,374
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	105	135	134	178	119
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	257	303	236	246	261
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,285	1,430	1,945	2,157	2,113
Total Liabilities & Shareholders' Equity	1,543	1,733	2,181	2,403	2,374
Total Common Shares Outstanding